X3 Acquisition
XCBEW · NASDAQ
XCBEW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 50
- Volume
- 200
- Open price
- $0.2099
- High today
- $0.2099
- Low today
- $0.2099
- 52 Week high
- $0.30
- 52 Week low
- $0.20
X3 Acquisition (XCBEW) at a glance
X3 Acquisition (XCBEW) last traded at $0.2099, with a price-to-earnings ratio of 0.00.
Volume so far is 200 shares, above the average of 50 shares a day.
Over the past year X3 Acquisition has ranged from $0.20 to $0.30, and now sits 10% of the way up that range.
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.